Cargando…

Assessing the risk of rapid fibroid growth in patients with asymptomatic solitary uterine myoma using a multivariate prediction model

BACKGROUND: Long-term conservative approaches are effective management options for asymptomatic uterine fibroids, but not for uterine myomas with excessive growth. In this investigation, a regression model was constructed to evaluate the clinical characteristics related to uterine fibroids’ growth....

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qingxiu, Zhong, Jiehui, Yi, Dongyi, Deng, Genqiang, Liu, Zezhen, Wang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033343/
https://www.ncbi.nlm.nih.gov/pubmed/33842591
http://dx.doi.org/10.21037/atm-20-4559
_version_ 1783676393640427520
author Li, Qingxiu
Zhong, Jiehui
Yi, Dongyi
Deng, Genqiang
Liu, Zezhen
Wang, Wei
author_facet Li, Qingxiu
Zhong, Jiehui
Yi, Dongyi
Deng, Genqiang
Liu, Zezhen
Wang, Wei
author_sort Li, Qingxiu
collection PubMed
description BACKGROUND: Long-term conservative approaches are effective management options for asymptomatic uterine fibroids, but not for uterine myomas with excessive growth. In this investigation, a regression model was constructed to evaluate the clinical characteristics related to uterine fibroids’ growth. METHODS: In this retrospective study, 19,840 patients with ultrasound-diagnosed uterine fibroids were identified from six centers between 2013 and 2019. In total, 739 patients were followed up for more than 1 year with B-ultrasound test results and clinical test results and had no acute events or surgical treatments. The endpoint was changed in the size of the uterine fibroids. Multivariate stepwise logistic regression analysis was used to identify predictors of uterine fibroid growth, and these were used to build a prediction model. The prediction model’s discrimination, calibration, and clinical efficacy were assessed using the area under the curve (AUC)/index of concordance (C-index), calibration plot, decision curve analysis, and clinical impact curve. Internal validation was performed using bootstrapping validation. A linear regression model was constructed to predict uterine fibroids’ growth rate without the occurrence of acute events. RESULTS: A total of 513 patients presented with significant growth of uterine fibroids, with an average follow-up time of 927 days, and 267 patients showed negative growth, with an average follow-up time of 960 days. Age, follicle-stimulating hormone (FSH), low-density lipoprotein (LDL), luteinizing hormone (LH), total cholesterol (TCHO), and neutrophil to lymphocyte ratio (NLR) were the main influential factors that predicted the uterine fibroid growth state, and these were used to develop a nomogram with predictive accuracy (AUC: 0.825). A linear regression prediction model was built based on the following factors: FSH, high-density lipoprotein (HDL), LH, triglyceride (TRIG), TCHO, and lymphocyte to monocyte ratio (LMR). The mean square error (MSE) was 0.32. CONCLUSIONS: This study directly measured the growth rate of uterine fibroids. A prediction model assessing the growth rate of asymptomatic uterine fibroids was established. This model is useful for the early detection of potentially rapidly growing uterine fibroids in patients.
format Online
Article
Text
id pubmed-8033343
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-80333432021-04-09 Assessing the risk of rapid fibroid growth in patients with asymptomatic solitary uterine myoma using a multivariate prediction model Li, Qingxiu Zhong, Jiehui Yi, Dongyi Deng, Genqiang Liu, Zezhen Wang, Wei Ann Transl Med Original Article BACKGROUND: Long-term conservative approaches are effective management options for asymptomatic uterine fibroids, but not for uterine myomas with excessive growth. In this investigation, a regression model was constructed to evaluate the clinical characteristics related to uterine fibroids’ growth. METHODS: In this retrospective study, 19,840 patients with ultrasound-diagnosed uterine fibroids were identified from six centers between 2013 and 2019. In total, 739 patients were followed up for more than 1 year with B-ultrasound test results and clinical test results and had no acute events or surgical treatments. The endpoint was changed in the size of the uterine fibroids. Multivariate stepwise logistic regression analysis was used to identify predictors of uterine fibroid growth, and these were used to build a prediction model. The prediction model’s discrimination, calibration, and clinical efficacy were assessed using the area under the curve (AUC)/index of concordance (C-index), calibration plot, decision curve analysis, and clinical impact curve. Internal validation was performed using bootstrapping validation. A linear regression model was constructed to predict uterine fibroids’ growth rate without the occurrence of acute events. RESULTS: A total of 513 patients presented with significant growth of uterine fibroids, with an average follow-up time of 927 days, and 267 patients showed negative growth, with an average follow-up time of 960 days. Age, follicle-stimulating hormone (FSH), low-density lipoprotein (LDL), luteinizing hormone (LH), total cholesterol (TCHO), and neutrophil to lymphocyte ratio (NLR) were the main influential factors that predicted the uterine fibroid growth state, and these were used to develop a nomogram with predictive accuracy (AUC: 0.825). A linear regression prediction model was built based on the following factors: FSH, high-density lipoprotein (HDL), LH, triglyceride (TRIG), TCHO, and lymphocyte to monocyte ratio (LMR). The mean square error (MSE) was 0.32. CONCLUSIONS: This study directly measured the growth rate of uterine fibroids. A prediction model assessing the growth rate of asymptomatic uterine fibroids was established. This model is useful for the early detection of potentially rapidly growing uterine fibroids in patients. AME Publishing Company 2021-03 /pmc/articles/PMC8033343/ /pubmed/33842591 http://dx.doi.org/10.21037/atm-20-4559 Text en 2021 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Li, Qingxiu
Zhong, Jiehui
Yi, Dongyi
Deng, Genqiang
Liu, Zezhen
Wang, Wei
Assessing the risk of rapid fibroid growth in patients with asymptomatic solitary uterine myoma using a multivariate prediction model
title Assessing the risk of rapid fibroid growth in patients with asymptomatic solitary uterine myoma using a multivariate prediction model
title_full Assessing the risk of rapid fibroid growth in patients with asymptomatic solitary uterine myoma using a multivariate prediction model
title_fullStr Assessing the risk of rapid fibroid growth in patients with asymptomatic solitary uterine myoma using a multivariate prediction model
title_full_unstemmed Assessing the risk of rapid fibroid growth in patients with asymptomatic solitary uterine myoma using a multivariate prediction model
title_short Assessing the risk of rapid fibroid growth in patients with asymptomatic solitary uterine myoma using a multivariate prediction model
title_sort assessing the risk of rapid fibroid growth in patients with asymptomatic solitary uterine myoma using a multivariate prediction model
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033343/
https://www.ncbi.nlm.nih.gov/pubmed/33842591
http://dx.doi.org/10.21037/atm-20-4559
work_keys_str_mv AT liqingxiu assessingtheriskofrapidfibroidgrowthinpatientswithasymptomaticsolitaryuterinemyomausingamultivariatepredictionmodel
AT zhongjiehui assessingtheriskofrapidfibroidgrowthinpatientswithasymptomaticsolitaryuterinemyomausingamultivariatepredictionmodel
AT yidongyi assessingtheriskofrapidfibroidgrowthinpatientswithasymptomaticsolitaryuterinemyomausingamultivariatepredictionmodel
AT denggenqiang assessingtheriskofrapidfibroidgrowthinpatientswithasymptomaticsolitaryuterinemyomausingamultivariatepredictionmodel
AT liuzezhen assessingtheriskofrapidfibroidgrowthinpatientswithasymptomaticsolitaryuterinemyomausingamultivariatepredictionmodel
AT wangwei assessingtheriskofrapidfibroidgrowthinpatientswithasymptomaticsolitaryuterinemyomausingamultivariatepredictionmodel